This site is intended for U.S. healthcare professionals.
Menu
Close
Menu
Close
Eligible, commercially insured patients may pay as little as $0 per month for BOSULIF® (bosutinib). Limits, terms, and conditions apply.
For more information, visit PfizerOncologyTogether.com/HCP or direct your patients to PfizerOncologyTogether.com/Patient
Terms & Conditions
By using this co-pay card, you acknowledge that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:
Pfizer Oncology Together Co-Pay Savings Program
2250 Perimeter Park Drive, Suite 300
Morrisville, NC 27560
1-month (30-day) free trial offer for patients initiating therapy
Patients who are new to therapy with BOSULIF may be eligible for a free 30-day trial offer. Terms and Conditions apply; see below.
For more information on the voucher program and to obtain a 30-day free trial offer, please contact Pfizer Oncology Together at 1-877-744-5675 or your local Pfizer Oncology representative.
Terms and Conditions for Trial Voucher Program
By enrolling in the 30-day trial program for BOSULIF, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below.
For more information, call 1-800-505-4426, contact Pfizer Inc. at 66 Hudson Blvd E, New York, NY 10001, or visit PfizerOncologyTogether.com.
Tailored
Informed
Connected
Apple® and Apple logo® are registered trademarks of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.
Patients can learn more about the MyTherapy® App at BOSULIF.com/resources
At Pfizer Oncology TogetherTM, patient support is at the core of everything we do. We've gathered resources and developed tools to help patients and their loved ones throughout BOSULIF treatment. From helping to identify financial assistance options to connecting patients to resources for emotional support, your patient's needs are our priority.
Pfizer Oncology Together can help patients understand their insurance benefits and connect them with financial assistance resources, regardless of their insurance coverage. Eligible, commercially insured patients may pay as little as $0 per month for BOSULIF. Limits, terms, and conditions apply. We can also help identify resources for patients with Medicare, Medicaid, other government insurance, or for those who don't have health insurance.
When patients need support for their day-to-day challenges, we can provide them with a dedicated Care Champion who has social work experience. Our Care Champions are here to listen to patients and connect them to resources that may help with certain emotional, educational, and practical needs.†
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.
Adult and pediatric patients 1 year of age and older with chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), newly-diagnosed or resistant or intolerant to prior therapy
BOSULIF is indicated for the treatment of:
Adult and pediatric patients 1 year of age and older with chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), newly-diagnosed or resistant or intolerant to prior therapy